Most foodies and wellness junkies have probably sampled kombucha, eaten jackfruit and tried CBD oil in the past few years as these once obscure products infiltrate the mainstream. But the truly hip will soon move on to sipping on pea milk, taking gaba supplements, and smearing their faces with bakuchiol.
Those are predictions from Black Swan, a London-based start-up that hoovers up data from social media, online forums, product review websites as well as other sources and then analyses it to divine what consumers want. Its artificial intelligence software purports to sift signal from noise to figure out which early trends are destined for mass adoption.
> Read the full article on the Financial Times website
By Leila Abboud
Source: Financial Times
Quartic.ai and Sparta Systems are collaborating on an AI-enabled risk detection software for pharmaceutical manufacturing operations, intended to increase both product quality and process efficiency. Their goal is to come […]
The modern company is a lot different from its predecessors. Innovation has changed how companies are organized, products are developed, and teams are led. All of this has been done for the better, with […]
With or without a pandemic, our future healthcare experiences will be radically different. That’s the premise on which our special guest, Naomi Fried will focus on the October 07 Borderless […]
